Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Journal of Chromatography. A|January 29, 2026
Comprehensive evaluation of reversed-phase and hydrophilic interaction liquid chromatography - mass spectrometry for analysis of gangliosidesMiroslav Lísa, Roman Hájek
Vnitrni Lekarstvi|December 29, 2018
CD38 targeted treatment for multiple myelomaTomáš Jelínek, Jana Mihályová, Roman Hájek
Journal of Chromatography. A|February 10, 2016
Hydrophilic interaction liquid chromatography-mass spectrometry of (lyso)phosphatidic acids, (lyso)phosphatidylserines and other lipid classesEva Cífková, Roman Hájek, Miroslav Lísa, et al.
British Journal of Haematology|January 25, 2022
Third dose of COVID-19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titresOndrej Šušol, Barbora Hájková, Hana Zelená, et al.
The International Journal of Artificial Organs|April 23, 2016
The effect of continuous elimination methods on the hemostatic profile of a cardiac surgery patient monitored using thromboelastographyOndřej Zuščich, Roman Hájek, Pavel Ševčík, et al.
Case Reports in Oncology|March 13, 2023
The Benefit of Telemonitoring in the Prevention of Septic Shock in a Patient with Aggressive Non-Hodgkin's LymphomaLucie Dudová, Katarína Hradská, Tereza Popková, et al.
BMC Cancer|September 21, 2012
Design and rationale of FOCUS (PX-171-011): a randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)Roman Hájek, Richard Bryce, Sunhee Ro, et al.
Analytical Chemistry|October 24, 2017
Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry Characterization of Gangliosides in Biological SamplesRoman Hájek, Robert Jirásko, Miroslav Lísa, et al.
Cardiovascular & Hematological Disorders Drug Targets|March 12, 2009
Chromatin structure and epigenetics of tumour cells: a reviewEva Bártová, Jana Krejcí, Roman Hájek, et al.
Cells|December 9, 2023
NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro AssessmentBenjamin Motais, Sandra Charvátová, Zuzana Walek, et al.
Pageof 12